
The latest thought leadership from our expert teams

Our core technology is at the heart of the world’s first FDA-approved fully at-home COVID-19 test
The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game changer in the global pandemic.
- Bioinnovation
- Digital health
- Fluids & thermodynamics
- Sensing

Beyond CES: shaping the business model for ‘product+’ consumer solutions
Walking the floor at CES, physically or virtually, can be overwhelming for anyone. The choice of solutions seems endless. If you're part of a consumer goods company, one that was born before the digital revolution, how do you navigate it?
- AI & Analytics
- Connectivity & IoT
- Digital services
- Product realisation
- Strategic advice

Building back better with digital service innovation
The urgent sustainability imperative is prompting a maze of evolving regulatory requirements in housebuilding. Thermal performance in new builds is mandated by regulations – yet there is currently no commercially viable verification method.
- Digital services
- Sensing

The future of AI is at the edge
Driven by advances in silicon and machine learning algorithms, Edge AI is presenting vast opportunities for businesses across diverse markets.
- AI & Analytics
- Connectivity & IoT
- Electronics & ASICs
- Signal processing

The path to successful telemedicine system architecture
Telemedicine is where telecommunication and healthcare converge.
- Connectivity & IoT
- Digital health
- Human factors
- Industrial design
- User Experience (UX)

How to spur climate targets in 2021 while juggling economic recovery from Covid-19?
Nathan Wrench, Head of Sustainability at Cambridge Consultants, joins Gulf Intelligence to discuss how to spur climate targets in 2021 while juggling economic recovery from Covid-19.
- Digital services
- Innovation management
- Strategic advice

Overcoming the regulatory challenges of smart ophthalmic devices
The ophthalmology world is welcoming a new wave of sophisticated implant technology designed to transform diagnosis and treatment.
- Digital health
- Human factors
- Physical sciences

The path to a sustainable future for inhalation products
Dan Cowen, Senior Consultant at Cambridge Consultants, presented at Drug Delivery to the Lungs (DDL) - Christmas Lectures and talked about the path to a sustainable future for inhalation products. Watch his presentation to learn how sustainability in inhalation products can be achieved whilst maintaining safety and efficacy at the core.
- Human factors
- User Experience (UX)

UK Human Tissue Authority licence enhances our next-generation therapy development
We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine.
- Bioinnovation

Medical device sustainability takes centre stage at DDL2020
Sustainability emerged as a hot and emotive topic at this year’s Drug Delivery to the Lungs (DDL) conference, read Donal Taylor's thoughts on other key trends that emerged.
- Human factors
- Industrial design
- Physical sciences
- Product realisation

Business survival in an age of net zero targets
Only two companies at the top of the Fortune 500 have survived from 20 years ago. The newcomers have risen by being fleet of foot or riding a financial or technological wave.
- AI & Analytics
- Digital services
- Optics
- Physical sciences
- Sensing

It’s time to start removing the barriers to sustainability in personal drug delivery devices
Matt Garwood challenges the medical device development status quo. If we embrace a bold, comprehensive response that begins at the concept stage and ends with the device user, it is possible to challenge conventional thinking and change for the better.
- Human factors
- Industrial design
- Physical sciences
- Product realisation